Absci (ABSI)
Designs antibody drug candidates with generative AI and validates them in its own wet lab.
$10.80
After-hours close+0.12 (+1.09%)
At close$10.69(+8.81%)
Something off on this page? Send us feedback.
Next report
Nov 16, 26
in 55 days
EPS estimate
−$0.19
Revenue estimate
$697.6K
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$0.25−$0.21−$0.24−$0.20−$0.23−$0.19−$0.18Pending
Estimate−$0.22−$0.23−$0.19−$0.19−$0.16−$0.20−$0.19−$0.19
Surprise−13.6%+8.7%−26.3%−5.3%−43.8%+5.0%+5.8%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported$665.0K$1.2M$593.0K$378.0K$650.0K$215.0K$300.0KPending
Estimate$4.9M$1.3M$5.2M$1.4M$1.3M$1.3M$919.6K$697.6K
Surprise−86.3%−9.3%−88.5%−72.6%−51.5%−82.9%−67.4%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2028 | $0.00 | — | — |
| Sep 2028 | $0.00 | — | — |
| Jun 2028 | $0.00 | — | — |
| Mar 2028 | $0.00 | — | — |
| Dec 2027 | −$0.14 | — | — |
| Sep 2027 | −$0.07 | — | — |
| Jun 2027 | −$0.16 | — | — |
| Mar 2027 | −$0.15 | — | — |
| Dec 2026 | −$0.19 | — | — |
| Nov 2026 | −$0.19 | — | — |
| Aug 2026 | −$0.19 | −$0.18 | +5.8% |
| May 2026 | −$0.20 | −$0.19 | +5.0% |
| Mar 2026 | −$0.16 | −$0.23 | −43.8% |
| Nov 2025 | −$0.19 | −$0.20 | −5.3% |
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Sep 2021 | |||
| Jul 2021 | |||
| Dec 2020 | |||
| Sep 2020 | |||
| Jun 2020 | |||
| Mar 2020 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2028 | $0.00 | — | — | $11.1M | — | — | — |
| Sep 2028 | $0.00 | — | — | $10.6M | — | — | — |
| Jun 2028 | $0.00 | — | — | $10.7M | — | — | — |
| Mar 2028 | $0.00 | — | — | $2.2M | — | — | — |
| Dec 2027 | −$0.14 | — | — | $5.4M | — | — | — |
| Sep 2027 | −$0.07 | — | — | $22.5M | — | — | — |
| Jun 2027 | −$0.16 | — | — | $4.7M | — | — | — |
| Mar 2027 | −$0.15 | — | — | $6.4M | — | — | — |
| Dec 2026 | −$0.19 | — | — | $1.1M | — | — | — |
| Nov 16, 2026 | −$0.19 | — | — | $697.6K | — | — | — |
| Aug 11, 2026 | −$0.19 | −$0.18 | +5.8% | $919.6K | $300.0K | −67.4% | +1.0% |
| May 7, 2026 | −$0.20 | −$0.19 | +5.0% | $1.3M | $215.0K | −82.9% | +2.6% |
| Mar 24, 2026 | −$0.16 | −$0.23 | −43.8% | $1.3M | $650.0K | −51.5% | −3.0% |
| Nov 12, 2025 | −$0.19 | −$0.20 | −5.3% | $1.4M | $378.0K | −72.6% | −22.4% |
| Aug 12, 2025 | |||||||
| May 13, 2025 | |||||||
| Mar 18, 2025 | |||||||
| Nov 12, 2024 | |||||||
| Aug 14, 2024 | |||||||
| May 14, 2024 | |||||||
| Mar 21, 2024 | |||||||
| Nov 14, 2023 | |||||||
| Aug 14, 2023 | |||||||
| May 15, 2023 | |||||||
| Mar 30, 2023 | |||||||
| Nov 9, 2022 | |||||||
| Aug 11, 2022 | |||||||
| May 11, 2022 | |||||||
| Mar 22, 2022 | |||||||
| Nov 9, 2021 | |||||||
| Sep 7, 2021 | |||||||
| Jul 23, 2021 | |||||||
| Dec 31, 2020 | |||||||
| Sep 30, 2020 | |||||||
| Jun 30, 2020 | |||||||
| Mar 31, 2020 |